Home - Biomagnetik Park
Building on the results of 20 years of research, we are creating a semi-open platform that for the first time opens up the huge potential for magnetocardiography (MCG) with the most sensitive quantum sensors for accurate diagnostics in cardiology, precision medicine and drug development. We will deliver a revolutionary MCG platform from 2027 consisting of:. Speed and accuracy are not opposites when using state-of-the-art methods. The power of the bmp diagnostic is founded on several basic electrophysical parameters/methods, developed by bmp 2005 – 2022. The results are based on datasets from 2002-2004 provided by the Klinikum Hoyerswerda, Germany. The PoC is based on long-term data sets provided by the Franz-Volhard-Klinik Charité Campus Buch (research group Prof. Magnetoionography (MIG) is a new method, derived from MCG and patented by bmp in August 2022, which allows for the first time to characterize these individual ion currents in heart muscle cells. Magnetorelaxometry (MRX) or superparamagnetic relaxometry (SPMR) is a technology that utilizes SQUID sensors and superparamagnetic nanoparticles (NPs) to detect diseased tissues.
This company is:
Keywords
Industries
How many employees does Biomagnetik Park AG approximately have?
As of the latest available information Biomagnetik Park AG has around 1-10 employees worldwide.
When was Biomagnetik Park AG founded?
Biomagnetik Park AG was founded in 2011
In which industries does Biomagnetik Park AG mainly work?
The company Biomagnetik Park AG has it's main focus in the industries of Health Care
Emergency MCG
2015
Genetesis
United States
11-50 Employees
2013
Magnetica Limited
Australia
51-100 Employees
2006
MagArray
United States
11-50 Employees
2005
MEDICAL GRAPHICS UK LTD
United Kingdom
1-10 Employees
MAG & More
Germany
1-10 Employees
2002
MagnaBioSciences
United States
1-10 Employees
2000
MGC Diagnostics Corporation
United States
51-100 Employees
1977
Topics which have been searched by others and may be interesting for you: